Project cooperationUpdated on 12 January 2026
Digital endpoint solution for motricity-affecting diseases seeks to join consortium for project call "DISEASE-03"
Senior Strategy & Scientific Affairs Director at Sysnav
Vernon, France
About
Sysnav Healthcare offers a real-world digital endpoint platform based on high-precision wearable sensors, to accelerate medical progress on diseases affecting motor function. Sysnav Healthcare’s solution provides the first regulatory-qualified digital endpoint: "SV95C", a measure of the patient's maximal gait speed. It also provides a number of endpoints assessing lower-limb and upper-limb motricity and has supported 100+ clinical studies.
Sysnav Healthcare's digital outcomes could help objectify and quantify the impact of post-infection long-term conditions affecting activity and mobility, such as long Covid, within a project answering to the call "HORIZON-HLTH-2026-01-DISEASE-03 - Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions".
Topic
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
Projects in Healthcare, Biotechnology, and Innovation
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
Flavia Marzulli
Project Collaborator at EuResist Network
Rome, Italy
Project cooperation
Digital health and data platform partner for post-infection long-term conditions
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
Konstantina Koutsiara
Project Manager at VIDAVO S.A.
Thessaloniki, Greece
Project cooperation
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
Zoltán Kovács
Co-founder and COO at FEMPHARMA Kft.
Debrecen, Hungary